[1P-0610] Novel candidate target genes of the hematopoietic transcription factor RUNX1 (AML1)

〇Kenjiro Tadagaki¹, Kenta Yamasaki¹, Noriko Kondo¹, Yasumichi Kuwahara¹, Tatsushi Yoshida¹, Tsukasa Okuda¹ (1.Dept of Biochem Molec Biol, Kyoto Pref. Univ. Med.)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1P-0611] The RUNX1/ETO fusion gene induces leukemia in an age-dependent manner

〇Mohamed Gaber Abdallah^1,2, Mariko Morii¹, Takako Ideue¹, Abdellah Ali Omar², Mabrouk M. AboElenin², Motomi Osato^1,3 (1.Laboratory of Runx Biology, IRCMS, Kumamoto University Japan, 2.Department of Medical Biochemistry, Faculty of Medicine Alazhar University, Egypt, 3.CSI National University of Singapore)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1P-0612] Molecular mechanism of Survivin expression in chronic myeloid leukemia (CML) cells

〇Kenta Moriyama¹, Konomi Maeda¹, Tomoya Namekawa¹, Ryotaro Nishi², Toshiyuki Hori¹ (1.Biomed. Sci., Grad. Sch. Sci., Ritsumeikan Univ., 2.Dept. Bio. Sci., College Life Sci., Ritsumeikan Univ.)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1P-0613] Development of a novel peptide-based therapeutic agent against CML by targeting PH domain of p210 BCR-ABL.

〇MASAYA CHODA¹, MIHO TAKAHASHI¹, KENTARO SHIMASAKI³, NORIHITO SHIBATA², MIKIHIKO NAITO², KIYOTAKA NISHIKAWA¹ (1.Faculty of Life and Medical Sciences, Univ of Doshisha, 2.Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 3.Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1P-0614] Immunosuppression of 4T1 tumor-bearing mice

〇Arihiro Kano¹, Masato Yamashita², Jing Gong², Moses K Kamita², Mitsuru Yamashita¹ (1.IMCE, Kyushu Univ, 2.IGSES, Kyushu Univ)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1P-0615] The analysis of the character of chemotherapy-resistant renal cell carcinomas based on global transcriptome analysis of their tissues and cell lines.

〇Takahiro Isono¹ (1.Central Research Laboratory, Shiga University of Medical Science)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1P-0616(1PW-15-3)] CD146 contributes the metastatic properties and antitumor immunity of human colon adenocarcinoma cells

〇Takumi Yamazaki¹, Kazunori Kato¹ (1.Dept. Cell. Mol. Med., Grad. Sch. Biomed. Eng., Toyo Univ.)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1P-0617] Transgelin overexpression induces malignant transformation in neuroblastoma cell.

〇Emi Yamaoka Yamaoka¹, Takahiro Fukazawa¹, Masami Kanawa¹, Yoko Kubo¹, Singo Kimura¹, Hirano Syouko¹, Eiso Hiyama¹ (1.NBARD, Hiroshima Univ.)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1P-0618] Epigenetic heterogeneity in triple-negative breast cancer

〇Reo Maruyama Maruyama¹, Liying Yang¹, Kohei Kumegawa¹, Tomoyoshi Nakadai¹ (1.Project for Cancer Epigenomics, Cancer Institute, JFCR)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[1P-0619] Screening for novel epithelial-mesenchymal transition-activating transcription factors in cancer cells

〇Minoru Terashima^1,2, Akihiko Ishimura^1,2, Tatsunori Nishimura³, Shoichiro Tange⁴, Kakeru Murata⁵, Keina Kadozaki⁵, Takeshi Suzuki^1,2 (1.Div of Func Genom, Cancer Res Inst, Kanazawa Univ, 2.Ins for Front Sci Init, Kanazawa Univ, 3.Div of Cancer Cell Biol, Cancer Res Inst, Kanazawa Univ, 4.Dept of Hum Genet, Grad Sch of Biomed Sci, Tokushima Univ, 5.GSC Prog, Kanazawa Univ)

The 41st Annual Meeting of the Molecular Biology Society of Japan